首页> 外文期刊>Journal of Medicinal Chemistry >Synthesis and biological activities of new checkpoint kinase 1 inhibitors structurally related to granulatimide
【24h】

Synthesis and biological activities of new checkpoint kinase 1 inhibitors structurally related to granulatimide

机译:结构上与格拉那肽有关的新型检查点激酶1抑制剂的合成和生物学活性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

In the course of structure-activity relationship studies on granulatimide analogues, new pyrrolo[3,4-c]-carbazoles in which the imidazole heterocycle has been replaced by a five- or a six-membered ring bearing one or two carbonyl functions have been synthesized. Their checkpoint kinase I (Chk1) inhibitory properties and their in vitro antiproliferative activities toward three tumor cell lines-murine leukemia L1210 and human colon carcinoma HT29 and HCT116 have been determined. The results of molecular modeling in the ATP binding pocket of Chk1 are described. Among the newly synthesized compounds, compounds 13 and 16, in which the imidazole was replaced by a quinone and a hydroquinone and which bear a hydroxy.,roup on the indole moiety, are the most potent Chk1 inhibitors in this series with IC50 values of 27 and 23 nM, respectively.
机译:在研究颗粒形式类似物的结构-活性关系的过程中,已经开发了新的吡咯并[3,4-c]-咔唑,其中的咪唑杂环被带有一个或两个羰基官能团的五元或六元环取代。合成的。已经确定了它们的检查点激酶I(Chk1)抑制特性及其对三种肿瘤细胞系-鼠白血病L1210和人结肠癌HT29和HCT116的体外抗增殖活性。描述了在Chk1的ATP结合口袋中进行分子建模的结果。在新合成的化合物中,其中咪唑被醌和对苯二酚取代并且在吲哚部分带有羟基的化合物13和16是该系列中最有效的Chk1抑制剂,IC50值为27和23 nM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号